From: Wip1 suppresses angiogenesis through the STAT3-VEGF signalling pathway in serous ovarian cancer
Wip1 staining | P value | ||
---|---|---|---|
Negative (n = 24) | Positive (n = 98) | ||
Median age | 57.0 years | 57.5 years | 0.684 |
FIGO stage | |||
III | 24 (100%) | 90 (91.8%) | |
IV | 0 | 8 (8.2%) | 0.353 |
Median preoperative serum CA125 | 1827.5 U/mL | 1507 U/mL | 0.478 |
Ascites volume | |||
≤ 500 mL | 1 (4.2%) | 27 (27.6%) | |
> 500 mL | 23 (95.8%) | 71 (72.4%) | 0.014 |
Bowel mesenteric metastasis | |||
No | 6 (25.0%) | 48 (49.0%) | |
Yes | 18 (75.0%) | 50 (51.0%) | 0.04 |
Diaphragm metastasis | |||
No | 3 (12.5%) | 41 (41.8%) | |
Yes | 21 (87.5%) | 57 (58.2%) | 0.008 |
TFI | |||
≤ 6 mos | 17 (70.8%) | 35 (35.7%) | |
> 6 mos | 5 (20.8%) | 59 (60.2%) | |
NA | 2 (8.3%) | 4 (4.1%) | 0.005 |